Dr. Julius W. Kim completed his Ph.D. in Biology at Saint Louis University in 2010. During his graduate studies, he focused on neuronal cell fate determination during development of Drosophila. He has further researched on adenovirus mediated immunotherapy and vaccine development at Washington University in Saint Louis as a post doctoral associate under Dr. David Curiel.  He has extensive experience with genetic modification of adenoviral vectors for a cell specific targeting. With the combination of his experience, his current work focuses on adenovirus mediated brain cancer therapy.


View a partial list of Dr. Kim's publications through the National Library of Medicine's PubMed online database.

Email: j[email protected]

---